Table 1

Characteristics of children with prolonged fever and their outcomes compared with children with shorter duration of fever

All children with fever <5 days
n=31 927 (89.4%)*
All children with fever ≥5 days
n=3778 (10.6%)*
P value
General characteristics
 AgeMedian (IQR)2.7 (1.3–5.5)3.0 (1.5–6.0)<0.001
 SexFemale, n (%)14 416 (45)1720 (46)0.68
 Previous visit to any healthcare provider in the last 7 daysn (%)7062 (23)1929 (55)<0.001
 Referraln (%)13 225 (43)1759 (48)<0.001
 Comorbidityn (%)5240 (17)583 (16)0.13
 Triage urgency classificationEmergent–very urgent3190 (10%)241 (6%)<0.001
Urgent7931 (25%)903 (24%)
Standard–non-urgent19 960 (63%)2527 (67%)
 Duration of feverDays, median (IQR)3 (3–4)6 (5–7)<0.001
Non-specific signs and symptoms
 Respiratory signs and symptomsAny9927 (37%)1560 (50%)<0.001
 Gastrointestinal signs and symptomsAny9677 (34%)1133 (34%)0.61
 Other type of rash†Any2806 (10%)479 (14%)<0.001
Warning signs and symptoms
 Ill appearancen (%)5101 (17)599 (17)0.97
 Tachypnoea (breaths/min)APLS thresholds, n (%)6139 (33)644 (32)0.19
 Tachycardia (beats/min)APLS thresholds, n (%)10 524 (42)993 (33)<0.001
 Prolonged capillary refill≥3 s, n (%)354 (1)53 (2)0.07
 Oxygen saturations (%O2)<94%O2, n (%)636 (3)126 (4)<0.001
 Level of consciousnessDecreased (verbal, pain, unresponsive), n (%)166 (1)14 (0.4)0.27
 Increased work of breathingn (%)4768 (17)481 (15)0.005
 Non-blanching rashn (%)926 (3)90 (3)0.09
 Neurological signsn (%)210 (1)24 (1)1.00
 Seizuresn (%)1261 (4)42 (1)<0.001
Diagnostics
 C-reactive proteinmg/L, median (IQR)17 (5–48)23 (6–64)<0.001
 Laboratory testing at EDAny, n (%)14 412 (45)2200 (58)<0.001
 Imaging at EDAny, n (%)5375 (17)1121 (30)<0.001
Treatment and outcomes
 Immediate life-saving interventions‡Any, n (%)513 (2)50 (1)0.21
 Antibiotics prescribed this attendanceAny, n (%)9857 (31)1560 (42)<0.001
 Diagnosis—focus of infectionUpper respiratory tract17 157 (54%)1861 (49%)<0.001
Lower respiratory tract4295 (13%)838 (22%)
Gastrointestinal3417 (11%)191 (5%)
Urinary tract1104 (3%)152 (4%)
Childhood exanthema1511 (5%)221 (6%)
Soft tissue or musculoskeletal748 (2%)92 (2%)
Sepsis or meningitis236 (1%)22 (1%)
Undifferentiated fever2559 (8%)247 (7%)
Inflammatory, other877 (3%)151 (4%)
 DiagnosisSerious bacterial infection1812 (5.7%)319 (8.4%)<0.001
Invasive bacterial infection129 (0.4%)15 (0.4%)1.00
 DispositionDischarge without follow-up11 393 (36%)1307 (35%)0.04
Discharge with follow-up12 288 (38%)1410 (37%)
Admission <24 hours1546 (5%)189 (5%)
Admission 24 hours or more5974 (19%)787 (21%)
Admission, duration unknown370 (1%)45 (1%)
PICU or death§125 (0.4%)18 (0.5%)
Left without being seen190 (1%)15 (0%)
  • *The MOFICHE study included a total of 38 480 febrile children7; n=2775 (7%) were excluded because of missing data on duration of fever.

  • †This excludes any non-blanching rash including petechiae and purpura.

  • ‡Immediate life-saving interventions (ILSI): airway and breathing support (non-rebreathing mask, (non-invasive) ventilation, intubation), emergency procedures (chest needle decompression, pericardiocentesis or open thoracotomy), haemodynamic support (fluid bolus (>10 mL/kg) or blood administration) or emergency medication (naloxone, dextrose, atropine, adenosine, epinephrine or vasopressors).

  • §In total, 1 death was recorded in the MOFICHE study, which had a duration of fever <5 days.

  • APLS, advanced paediatric life support; ED, emergency department; MOFICHE, Management and Outcome of Fever in Children in Europe; PICU, paediatric intensive care unit.